Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31 USD | +7.64% | +1.61% | -24.57% |
May. 14 | Transcript : Sanara MedTech Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 13 | Sanara MedTech Q1 Net Loss Widens, Revenue Increases -- Shares Down | MT |
Financials (USD)
Sales 2024 * | 78M | Sales 2025 * | - | Capitalization | 267M |
---|---|---|---|---|---|
Net income 2024 * | -1M | Net income 2025 * | 4M | EV / Sales 2024 * | 3.43 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-141
x | P/E ratio 2025 * |
55.4
x | Employees | 108 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 39.95% |
Latest transcript on Sanara MedTech Inc.
1 day | +7.64% | ||
1 week | +1.61% | ||
Current month | -2.64% | ||
1 month | -4.62% | ||
3 months | -18.36% | ||
6 months | -5.52% | ||
Current year | -24.57% |
Managers | Title | Age | Since |
---|---|---|---|
Michael McNeil
DFI | Director of Finance/CFO | 59 | 18-04-10 |
Chief Tech/Sci/R&D Officer | - | 22-12-31 | |
Chief Tech/Sci/R&D Officer | 39 | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Tanzberger
BRD | Director/Board Member | 55 | 21-12-31 |
Roszell Mack
BRD | Director/Board Member | 57 | 21-12-31 |
Eric Major
BRD | Director/Board Member | 55 | 23-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +4.20% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 31 | +7.64% | 23,444 |
24-05-23 | 28.8 | -4.89% | 36,223 |
24-05-22 | 30.28 | -3.90% | 15,276 |
24-05-21 | 31.51 | -3.14% | 6,321 |
24-05-20 | 32.53 | +6.62% | 12,948 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.57% | 267M | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- SMTI Stock